What is Ryeqo used for?

( ARTG ) Ryeqo is indicated in adult women of reproductive age for:, treatment of moderate to severe symptoms of uterine fibroids,,symptomatic treatment of endometriosis in women with a history of previous medical or surgical treatment for their endometriosis (see section 5.1 PHARMACODYNAMIC PROPERTIES).

What are the side effects of Ryeqo?

This medicine is under additional monitoring as it is new or being used in a different way. You can help identify new safety information by reporting any side effects you may get. You can report side effects to your doctor, or directly at www.tga.gov.au/reporting-problems . For more information on the Black Triangle Scheme and how to report side effects, see www.tga.gov.au/black-triangle-scheme

Can Ryeqo be used during pregnancy?

( AHT ) For the active ingredient relugolix + estradiol + norethisterone acetate You should seek advice from your doctor or pharmacist about taking this medicine. They can help you balance the risks and the benefits of this medicine during pregnancy.

What ATC class does Ryeqo belong to?

Ryeqo: ATC H01CC54. ATC is the WHO Anatomical Therapeutic Chemical classification — it groups drugs by organ system and pharmacological mechanism.

OTC

Ryeqo

INN: relugolix;estradiol;norethisterone acetate

Data updated: 2026-05-02

Available in:

🇨🇿🇩🇪🇬🇧🇸🇰

Form

—

Dosage

—

Route

—

Storage

—

About This Product

Manufacturer

User Reviews

Reviews reflect personal experiences and are not medical advice. Always consult your doctor.